Clinical trial: Inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects

@article{Kim2010ClinicalTI,
  title={Clinical trial: Inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects},
  author={Hyung-Keun Kim and S. Park and D. Cheung and Y. Cho and Jin-Il Kim and S. Kim and H. Chae and J. Kim and I. Chung},
  journal={Journal of Gastroenterology and Hepatology},
  year={2010},
  volume={25}
}
Background and Aim:  Revaprazan is a novel acid pump antagonist. The aim of this study was to investigate the inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects. 
26 Citations
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects
  • 3
Potent Acid Suppression with PPIs and P-CABs: What’s New?
  • 17
Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases
  • 24
  • PDF
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations
  • 9
  • PDF
Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid–Related Disease
  • 7
  • Highly Influenced
  • PDF
Vonoprazan fumarate for the management of acid-related diseases
  • 12
...
1
2
3
...

References

SHOWING 1-10 OF 34 REFERENCES
Time to maximum effect of lansoprazole on gastric pH in normal male volunteers
  • 43
The proton-pump inhibitors: similarities and differences.
  • J. Horn
  • Medicine
  • Clinical therapeutics
  • 2000
  • 215
Ambulatory gastric pH monitoring: proper probe placement and normal values
  • 31
...
1
2
3
4
...